Newhall Charles W Iii Insider Trades

Insider Trading History

Track insider trading activity for Newhall Charles W Iii. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 24, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$239k 4,475 shares
$53.30
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $5.55M 124,119 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 4,475 shares
$53.30
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $134k 2,989 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 2,989 shares
$50.20
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $222k 4,977 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 4,977 shares
$50.20
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $5.35M 119,644 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$680k 15,000 shares
$45.32
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Nov 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$680k 15,000 shares
$45.32
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $4.73M 105,844 shares
Last Trade
Oct 09, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.27M 25,000 shares
$50.77
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $5.8M 129,644 shares
Last Trade
Aug 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$161k 3,588 shares
$45.01
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $5.96M 133,232 shares
Last Trade
Aug 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$45k 1,000 shares
$45.00
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $6M 134,232 shares
Last Trade
Aug 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.5k 1,412 shares
$45.00
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 22, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$177k 5,369 shares
$33.05
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $6.06M 135,644 shares
Last Trade
Feb 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$177k 5,369 shares
$33.05
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $326k 7,296 shares
Last Trade
Feb 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 7,296 shares
$33.52
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $5.82M 130,275 shares
Last Trade
Nov 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$388k 10,700 shares
$36.24
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Nov 11, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$732k 20,000 shares
$36.61
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $6.3M 140,975 shares
Last Trade
Nov 11, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$732k 20,000 shares
$36.61
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $5.41M 120,975 shares
Last Trade
Feb 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 3,886 shares
$29.06
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$113k 3,886 shares
$29.06
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $369k 8,252 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 8,252 shares
$27.94
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $5.23M 117,089 shares
Last Trade
Nov 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$70k 2,500 shares
$28.01
$44.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up